
Lateral Flow Assays Market by Product (Kits & Reagents, Lateral Flow Readers), Technique (Competitive Assays, Multiplex Detection Assays, Sandwich Assays), Test Type, Application, End-User - Global Forecast 2024-2030
Description
Lateral Flow Assays Market by Product (Kits & Reagents, Lateral Flow Readers), Technique (Competitive Assays, Multiplex Detection Assays, Sandwich Assays), Test Type, Application, End-User - Global Forecast 2024-2030
The Lateral Flow Assays Market size was estimated at USD 9.65 billion in 2023 and expected to reach USD 10.03 billion in 2024, at a CAGR 4.30% to reach USD 12.96 billion by 2030.
Global Lateral Flow Assays Market The lateral flow assay is widely utilized to detect the presence of one or more target analytes, such as microbes, in a liquid sample. These diagnostic devices are usedf for various purposes, including the detection of diabetes and kidney failure. The usage of lateral flow assays has increased, owing to easy test procedures and low sample volume requirement, without the need for expert personnel and low cost of operation. These lateral flow assays are being developed for various disease markers, including PSA, commonly elevated by prostate cancer, and C-reactive protein (CRP). Additionally, lateral flow assay is used to screen for animal diseases, monitor water quality, and detect biological infectious agents and chemical contaminants in biological samples.The demand for lateral flow assay is significantly growing across the food & beverage industry for detecting pathogens, including Salmonella, and Listeria, in food samples and testing food quality, contributing to the growth of the lateral flow assay market. However, inconsistent results and low accuracy of lateral flow assay tests are hampering the market's growth. Technological advancements and R & D activities associated with lateral flow assays are creating opportunities for market growth.Regional InsightsGermany, the U.S., Brazil, China, South Korea, and Europe are heavily investing in research and development R&D to develop effective drugs, which has expanded the need for lateral flow assays for clinical and drug testing and are propelling the growth of the market. Additionally, the growing number of clinical trials across Asia-Pacific regions in China, India, Vietnam, and South Korea owing to government funding for research and development R&D are creating opportunities for the market. Moreover, the U.S. is a technologically advanced nation, and the utilization of innovative manufacturing technologies for drugs is subsequently expanding the lateral flow assays market across North America. The increasing food consumption, including frozen dairy products and government regulations for maintaining the safety and quality of food across Middle East nations, are contributing to the growth of the market.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Lateral Flow Assays Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Lateral Flow Assays Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Lateral Flow Assays Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Inc., Abcam PLC, BBI Solutions, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corp., BioFluidix GmbH by Hamilton Company, BioMérieux SA, BioPorto Diagnostics A/S, BOC Sciences, Cytodiagnostics Inc., Danaher Corporation, Elabscience Biotechnology Inc., F. Hoffmann-La Roche AG, Fortis Life Sciences, Hologic, Inc., Leinco Technologies, Merck KGaA, Microcoat Biotechnologie GmbH, Milenia Biotec GmbH, PerkinElmer Inc., Porex Filtration Group, QIAGEN GmbH, Quidel Corporation, R-Biopharm AG, Rockland Immunochemicals, Inc., Shenzhen SEKBIO Co., Ltd., Siemens AG, Tetracore, Inc., Thermo Fisher Scientific, Inc., and VDO Biotech Co., Ltd..
Market Segmentation & Coverage
This research report categorizes the Lateral Flow Assays Market to forecast the revenues and analyze trends in each of the following sub-markets:
Product
Kits & Reagents
Lateral Flow Readers
Benchtop Readers
Digital or Handheld Readers
Mobile or Smartphone Readers
Technique
Competitive Assays
Multiplex Detection Assays
Sandwich Assays
Test Type
Lateral Flow Immunoassay
Nucleic Acid Lateral Flow Assay
Application
Clinical Testing
Drug Development & Quality Testing
Food Safety & Environment Testing
Veterinary Diagnostics
End-User
Diagnostic Laboratories
Home Care Settings
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Lateral Flow Assays Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Lateral Flow Assays Market?
3. What are the technology trends and regulatory frameworks in the Lateral Flow Assays Market?
4. What is the market share of the leading vendors in the Lateral Flow Assays Market?
5. Which modes and strategic moves are suitable for entering the Lateral Flow Assays Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
187 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Lateral Flow Assays Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rising prevalence of infectious diseases across the globe
- 5.1.1.2. Growing adoption of lateral flow assay devices in home care settings
- 5.1.1.3. Increasing demand for lateral flow assay from food & beverage industry for testing of food quality
- 5.1.2. Restraints
- 5.1.2.1. Low accuracy and inconsistent results of lateral flow assay tests
- 5.1.3. Opportunities
- 5.1.3.1. Technological advancements and increase in R&D activities associated with lateral flow assays
- 5.1.3.2. Emergence of point-of-care testing for rapid provision of test results
- 5.1.4. Challenges
- 5.1.4.1. Concerns about image processing using mobile POC diagnostics
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Lateral Flow Assays Market, by Product
- 6.1. Introduction
- 6.2. Kits & Reagents
- 6.3. Lateral Flow Readers
- 6.4.1. Benchtop Readers
- 6.4.2. Digital or Handheld Readers
- 6.4.3. Mobile or Smartphone Readers
- 7. Lateral Flow Assays Market, by Technique
- 7.1. Introduction
- 7.2. Competitive Assays
- 7.3. Multiplex Detection Assays
- 7.4. Sandwich Assays
- 8. Lateral Flow Assays Market, by Test Type
- 8.1. Introduction
- 8.2. Lateral Flow Immunoassay
- 8.3. Nucleic Acid Lateral Flow Assay
- 9. Lateral Flow Assays Market, by Application
- 9.1. Introduction
- 9.2. Clinical Testing
- 9.3. Drug Development & Quality Testing
- 9.4. Food Safety & Environment Testing
- 9.5. Veterinary Diagnostics
- 10. Lateral Flow Assays Market, by End-User
- 10.1. Introduction
- 10.2. Diagnostic Laboratories
- 10.3. Home Care Settings
- 10.4. Hospitals & Clinics
- 10.5. Pharmaceutical & Biotechnology Companies
- 11. Americas Lateral Flow Assays Market
- 11.1. Introduction
- 11.2. Argentina
- 11.3. Brazil
- 11.4. Canada
- 11.5. Mexico
- 11.6. United States
- 12. Asia-Pacific Lateral Flow Assays Market
- 12.1. Introduction
- 12.2. Australia
- 12.3. China
- 12.4. India
- 12.5. Indonesia
- 12.6. Japan
- 12.7. Malaysia
- 12.8. Philippines
- 12.9. Singapore
- 12.
- 10. South Korea
- 12.
- 11. Taiwan
- 12.
- 12. Thailand
- 12.
- 13. Vietnam
- 13. Europe, Middle East & Africa Lateral Flow Assays Market
- 13.1. Introduction
- 13.2. Denmark
- 13.3. Egypt
- 13.4. Finland
- 13.5. France
- 13.6. Germany
- 13.7. Israel
- 13.8. Italy
- 13.9. Netherlands
- 13.
- 10. Nigeria
- 13.
- 11. Norway
- 13.
- 12. Poland
- 13.
- 13. Qatar
- 13.
- 14. Russia
- 13.
- 15. Saudi Arabia
- 13.
- 16. South Africa
- 13.
- 17. Spain
- 13.
- 18. Sweden
- 13.
- 19. Switzerland
- 13.
- 20. Turkey
- 13.
- 21. United Arab Emirates
- 13.
- 22. United Kingdom
- 14. Competitive Landscape
- 14.1. FPNV Positioning Matrix
- 14.2. Market Share Analysis, By Key Player
- 14.3. Competitive Scenario Analysis, By Key Player
- 14.3.1. Merger & Acquisition
- 14.3.1.1. Thermo Fisher Scientific Completes Acquisition of The Binding Site Group
- 14.3.2. Agreement, Collaboration, & Partnership
- 14.3.2.1. University of Birmingham signs licensing deal with world’s largest COVID-19 test provide
- 14.3.2.2. Alamar and Mologic collaborate to develop sensitive COVID-19 tests
- 14.3.2.3. Strategic Collaboration With Vatic Health
- 14.3.3. New Product Launch & Enhancement
- 14.3.3.1. Boots launches new COVID-19 lateral flow tests as government announces plans to limit free testing
- 14.3.3.2. UKHSA launches app to help blind people read lateral flow test results
- 14.3.4. Investment & Funding
- 14.3.4.1. Senzo receives USD 1.9m investment for point-of-care diagnostics
- 14.3.4.2. Welsh lateral flow specialist secures further £1m (USD 1.34 million) investment
- 14.3.5. Award, Recognition, & Expansion
- 14.3.5.1. QuidelOrtho COVID test is first to win FDA nod via premarket review
- 14.3.5.2. First rapid lateral flow test for COVID and flu approved in UK
- 14.3.5.3. SCIENION announces expansion in the UK with the opening of new R&D and manufacturing facilities
- 14.3.5.4. CTDA approval for Everything Genetic’s lateral flow test confirmed
- 15. Competitive Portfolio
- 15.1. Key Company Profiles
- 15.1.1. Abbott Laboratories, Inc.
- 15.1.2. Abcam PLC
- 15.1.3. BBI Solutions
- 15.1.4. Becton, Dickinson and Company
- 15.1.5. Bio-Rad Laboratories, Inc.
- 15.1.6. Bio-Techne Corp.
- 15.1.7. BioFluidix GmbH by Hamilton Company
- 15.1.8. BioMérieux SA
- 15.1.9. BioPorto Diagnostics A/S
- 15.1.
- 10. BOC Sciences
- 15.1.
- 11. Cytodiagnostics Inc.
- 15.1.
- 12. Danaher Corporation
- 15.1.
- 13. Elabscience Biotechnology Inc.
- 15.1.
- 14. F. Hoffmann-La Roche AG
- 15.1.
- 15. Fortis Life Sciences
- 15.1.
- 16. Hologic, Inc.
- 15.1.
- 17. Leinco Technologies
- 15.1.
- 18. Merck KGaA
- 15.1.
- 19. Microcoat Biotechnologie GmbH
- 15.1.
- 20. Milenia Biotec GmbH
- 15.1.
- 21. PerkinElmer Inc.
- 15.1.
- 22. Porex Filtration Group
- 15.1.
- 23. QIAGEN GmbH
- 15.1.
- 24. Quidel Corporation
- 15.1.
- 25. R-Biopharm AG
- 15.1.
- 26. Rockland Immunochemicals, Inc.
- 15.1.
- 27. Shenzhen SEKBIO Co., Ltd.
- 15.1.
- 28. Siemens AG
- 15.1.
- 29. Tetracore, Inc.
- 15.1.
- 30. Thermo Fisher Scientific, Inc.
- 15.1.
- 31. VDO Biotech Co., Ltd.
- 15.2. Key Product Portfolio
- 16. Appendix
- 16.1. Discussion Guide
- 16.2. License & Pricing
- FIGURE 1. LATERAL FLOW ASSAYS MARKET RESEARCH PROCESS
- FIGURE 2. LATERAL FLOW ASSAYS MARKET SIZE, 2023 VS 2030
- FIGURE 3. LATERAL FLOW ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. LATERAL FLOW ASSAYS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. LATERAL FLOW ASSAYS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. LATERAL FLOW ASSAYS MARKET DYNAMICS
- FIGURE 7. LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
- FIGURE 8. LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
- FIGURE 10. LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. LATERAL FLOW ASSAYS MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
- FIGURE 12. LATERAL FLOW ASSAYS MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 14. LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. LATERAL FLOW ASSAYS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
- FIGURE 16. LATERAL FLOW ASSAYS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. AMERICAS LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. AMERICAS LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 20. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. ASIA-PACIFIC LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 22. ASIA-PACIFIC LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 23. EUROPE, MIDDLE EAST & AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 24. EUROPE, MIDDLE EAST & AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 25. LATERAL FLOW ASSAYS MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 26. LATERAL FLOW ASSAYS MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.